cefaclor anhydrous has been researched along with Asthma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Ge, L; He, Q; Liu, W; Ma, C; Xu, S; Zhang, L; Zhou, L | 1 |
| Hogan, C | 1 |
| Braschi, R; Moreo, G; Nani, M; Remotti, G; Sardi, C | 1 |
1 trial(s) available for cefaclor anhydrous and Asthma
| Article | Year |
|---|---|
[Comparison of an antibiotic combination (amoxicillin + clavulanic acid) and cefaclor in the treatment of acute or flare-ups of chronic bronchopneumopathies].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Asthma; Bronchitis; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1988 |
2 other study(ies) available for cefaclor anhydrous and Asthma
| Article | Year |
|---|---|
Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis.
Topics: Ajmaline; Aminoglutethimide; Asthma; Bethanechol; Biomarkers; Cefaclor; Computational Biology; Cytokines; Dimenhydrinate; Ethionamide; Gene Expression Profiling; Humans; Iloprost; Indoprofen; JNK Mitogen-Activated Protein Kinases; Levobunolol; Mimosine; Mitogen-Activated Protein Kinases; Myeloid Differentiation Factor 88; Neutrophils; NF-kappa B; NLR Proteins; Receptors, Cytokine; Toll-Like Receptor 2; Trapidil; Triggering Receptor Expressed on Myeloid Cells-1 | 2022 |
The near fatal lick.
Topics: Adult; Anaphylaxis; Asthma; Cefaclor; Dermatitis, Atopic; Drug Hypersensitivity; Epinephrine; Female; Follow-Up Studies; Humans; Oxygen; Treatment Outcome | 2001 |